DNP:GPWDino Polska SA Analysis
Data as of 2026-05-27 - not real-time
$10.85
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
DNP is trading at $10.85, comfortably above its 20‑day SMA of $10.73 and the 50‑day SMA of $10.53, confirming a bullish price structure. The 14‑day RSI at 60 indicates modest momentum without being overbought. MACD shows a bullish crossover with the line above its signal, and the histogram turning positive. Volume has remained stable, supporting the technical picture. The fund’s dividend yield of 7.16% is among the highest in its sector, with a payout ratio of roughly 67%. Recent distribution notices confirm that the dividend policy remains active.
On the valuation side, the trailing PE of 9.35 is well below the industry average of 16.6, suggesting the stock is undervalued. A price‑to‑book of 1.17 and a solid operating cash flow of $236 M further reinforce the cheapness. Leverage is elevated (debt‑to‑equity ≈ 31.5), but the fund’s net asset value is supported by strong cash generation. Volatility over the past 30 days sits at about 10.8%, while beta of 0.26 points to low market sensitivity. The utility‑focused investment mandate adds defensive characteristics, keeping sector risk low. Overall, the combination of attractive yield, defensive positioning, and relative undervaluation makes DNP a compelling income play.
On the valuation side, the trailing PE of 9.35 is well below the industry average of 16.6, suggesting the stock is undervalued. A price‑to‑book of 1.17 and a solid operating cash flow of $236 M further reinforce the cheapness. Leverage is elevated (debt‑to‑equity ≈ 31.5), but the fund’s net asset value is supported by strong cash generation. Volatility over the past 30 days sits at about 10.8%, while beta of 0.26 points to low market sensitivity. The utility‑focused investment mandate adds defensive characteristics, keeping sector risk low. Overall, the combination of attractive yield, defensive positioning, and relative undervaluation makes DNP a compelling income play.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish technical indicators (SMA alignment, MACD crossover)
- Support level around $10.58 providing downside cushion
- High dividend yield offering immediate income
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation relative to industry peers
- Strong operating cash flow supporting dividend sustainability
- Low beta and moderate volatility indicating defensive profile
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustainable dividend payout with solid cash generation
- Defensive utility exposure limiting sector downside
- Long‑term price appreciation potential from value discount
Key Metrics & Analysis
Financial Health
Revenue Growth8.90%
Profit Margin266.32%
P/E Ratio9.4
ROE12.67%
ROA1.78%
Debt/Equity31.58
P/B Ratio1.2
Op. Cash Flow$235.9M
Free Cash Flow$64.1M
Industry P/E16.6
Technical Analysis
TrendBullish
RSI60.2
Support$10.58
Resistance$10.91
MA 20$10.73
MA 50$10.53
MA 200$10.19
MACDBullish
VolumeStable
Fear & Greed Index92.34
Valuation
Fair Value$0.40
GradeUndervalued
TypeValue
Dividend Yield7.16%
Risk Assessment
Beta0.26
Volatility10.79%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.